Some chemotherapy drugs, such as anthracyclines (e.g., doxorubicin) and tyrosine kinase inhibitors (e.g., imatinib), are known to have cardiotoxic effects. These drugs can lead to changes in the heart's electrical activity, causing arrhythmias. The risk is often dose-dependent and may increase with prolonged exposure to these medications.
